New drug to prevent migraine may start working right away.

A recent study published in Neurology(R) suggests that a newly approved drug, atogepant, may start working immediately to prevent migraines. The drug, a calcitonin gene-related peptide (CGRP) receptor antagonist taken orally, was found to reduce the frequency of migraines in participants compared to a placebo. The study highlighted the need for effective and fast-acting migraine treatments, as migraines can significantly impact individuals' quality of life. However, it is important to note that the study primarily included female and white participants, so the results may not be generalizable to the entire population. [Extracted from the article]